• Latest Posts

This has been the Worst Financial Year for Biotech in a Decade

Up, up and away! CureVac’s money pile now Totals €325M

One Step Closer to an HIV Cure That Can Eliminate the Latent Virus

Researchers Find New Weak Spots to Develop an HIV Cure

Interview: This Biotech Could Have the First HIV Cure on the Market

ADVERTISEMENT

While working on its HIV Cure, Gilead gives Europe an ‘HIV Vaccine’

Gilead licenses Danish Bispecific antibodies for the next HIV Cure

How did Helen Lee overcome barriers to HIV Diagnostics in the ‘Real World’?

On the way to a ‘Functional’ HIV Cure? Norway Vaccine clears viral load in 88% of Patients

“We have one of the World’s Most Advanced Functional HIV Cures under development”

Immunotherapy reaches Breakthrough in eliminating HIV

ADVERTISEMENT